Dilated cardiomyopathy is a serious heart muscle disease in dogs. Understanding its progression helps owners support affected dogs through evidence-based management and quality of life assessment.
DCM presents distinctive welfare challenges because the occult pre-clinical phase means owners may not recognize their dog is seriously ill until heart failure develops. Dogs in occult DCM may carry dangerous arrhythmias — electrical heart disturbances that cause sudden death — without outward signs. Doberman Pinscher screening programs using echocardiography and Holter monitoring catch dogs in this phase and allow treatment to prevent sudden cardiac death. Once overt heart failure develops, management mirrors that for valve disease: pimobendan, diuretics, and antiarrhythmic drugs improve comfort and extend life. Quality of life assessment is particularly important in DCM because the combination of weakness, breathlessness, and medication side effects can significantly reduce wellbeing.